| Kenneth W Ordene, MD | |
|
501 Iron Bridge Road, Suite 12, Freehold, NJ 07728 | |
| (732) 780-0002 | |
| (732) 308-0117 |
| Full Name | Kenneth W Ordene |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 47 Years |
| Location | 501 Iron Bridge Road, Freehold, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750472205 | NPI | - | NPPES |
| 4058855 | Other | AETNA | |
| 76A38 | Other | EMPIRE | |
| VS120 | Other | NJ | OXFORD |
| 3162109 | Medicaid | NJ | |
| 6159202 | Other | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MA040391 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centrastate Medical Center | Freehold, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the second quarter ended March 31, 2010.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
The University of Manchester study used embryonic stem (ES) cells to investigate how some tumours are able to migrate to other parts of the body, which makes the treatment of cancer much more difficult.
› Verified 2 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the second quarter ended March 31, 2010.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
The University of Manchester study used embryonic stem (ES) cells to investigate how some tumours are able to migrate to other parts of the body, which makes the treatment of cancer much more difficult.
› Verified 2 days ago
| Entity Name | Endocrinology Associates Of Central New Jersey Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821256470 PECOS PAC ID: 2365510039 Enrollment ID: O20081008000081 |
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the second quarter ended March 31, 2010.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
The University of Manchester study used embryonic stem (ES) cells to investigate how some tumours are able to migrate to other parts of the body, which makes the treatment of cancer much more difficult.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth W Ordene, MD 501 Iron Bridge Road, Suite 12, Freehold, NJ 07728 Ph: (732) 780-0002 | Kenneth W Ordene, MD 501 Iron Bridge Road, Suite 12, Freehold, NJ 07728 Ph: (732) 780-0002 |
News Archive
After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the second quarter ended March 31, 2010.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
The University of Manchester study used embryonic stem (ES) cells to investigate how some tumours are able to migrate to other parts of the body, which makes the treatment of cancer much more difficult.
› Verified 2 days ago
Dr. Kunal Gupta, M.D.,,M.B.A Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 222 Schanck Rd, Suite 302, Freehold, NJ 07728 Phone: 732-577-1999 Fax: 732-845-5356 | |
Dr. Ashish Awasthi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 901 W Main St Ste 205, Cn 5050, Freehold, NJ 07728 Phone: 732-866-0800 Fax: 732-866-0018 | |
Dr. Colin Christopher Brown, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 222 Schanck Rd, Suite 302, Freehold, NJ 07728 Phone: 732-577-1999 Fax: 732-845-5356 | |
Dr. Rudolph Harold Borgersen, Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 501 Stillwells Corner Rd, Freehold, NJ 07728 Phone: 732-780-3330 Fax: 732-780-4385 | |
Dr. Fiolakemi Sowemimo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 901 W Main St, Suite 103, Freehold, NJ 07728 Phone: 732-252-6688 Fax: 732-761-9705 | |
Dr. Pinakin Chimanbhai Patel, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12 Russell Rd, Freehold, NJ 07728 Phone: 732-577-7977 | |
Dr. Bhavesh Vasant Balar, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 326 Professional View Dr, Freehold, NJ 07728 Phone: 732-431-8400 Fax: 732-431-0114 |